Actualités AXM Pharma Inc (EM) - AXMP | Actions OTC Markets

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

Premium

Current Report Filing (8-k)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM...

Termination of Registration of a Class of Security Under Section 12(b) (15-12b)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 15 CERTIFICATION AND NOTICE OF...

- Current report filing (8-K)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT...

Cord Blood America Updates Investors on China and Las Vegas Operations

Cord Blood America Updates Investors on China and Las Vegas Operations PR Newswire LAS VEGAS, May 4 LAS VEGAS, May 4 /PRNewswire-FirstCall/...

Cord Blood America's CEO Matthew Schissler, In Analyst Interview, Discusses China Expansion

Cord Blood America's CEO Matthew Schissler, In Analyst Interview, Discusses China Expansion PR Newswire LAS VEGAS, April 1 LAS VEGAS, April 1...

Cord Blood America Signs License Agreement to Operate Stem Cell Collection Business in China

Cord Blood America Signs License Agreement to Operate Stem Cell Collection Business in China PR Newswire LAS VEGAS, March 31 LAS VEGAS, March 31...

- Current report filing (8-K)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K ...

- Current report filing (8-K)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K ...

- Amended Annual Report (10-K/A)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 _____________________ FORM 10-K AMENDMENT 2 x ANNUAL REPORT...

Axm Pharma Inc - Statement of Ownership (SC 13G)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ...

Axm Pharma Inc - Statement of Ownership (SC 13G)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ...

Axm Pharma Inc - Current report filing (8-K)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or...

AXM Pharma Receives $2.65 Million Investment From Beida Wei Ming Bioproduct Co., Ltd.

AXM Pharma (OTC: AXMP) announced today that it has entered into an agreement with Beida Wei Ming Bioproduct Co., Ltd. (?Beida...

AXM Pharma Hires Leading Chinese Pharmaceutical Sales Executives To Support Growth

AXM Pharma Inc. (OTC: AXMP) a manufacturer of proprietary and generic pharmaceutical and nutraceutical products for the Chinese...

AXM Pharma Appoints Steven M. Dinh to Its Board of Directors

AXM Pharma, Inc. (OTC: AXMP), a manufacturer of proprietary and generic pharmaceutical and nutraceutical products for the Chinese and other Asian...

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

AXM Pharma Inc (EM) (AXMP)

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

AXM Pharma Inc (EM) (AXMP) Actualités

Current Report Filing (8-k)

Termination of Registration of a Class of Security Under Section 12(b) (15-12b)

- Current report filing (8-K)

Cord Blood America Updates Investors on China and Las Vegas Operations

Cord Blood America's CEO Matthew Schissler, In Analyst Interview, Discusses China Expansion

Cord Blood America Signs License Agreement to Operate Stem Cell Collection Business in China

- Current report filing (8-K)

- Current report filing (8-K)

- Amended Annual Report (10-K/A)

Axm Pharma Inc - Statement of Ownership (SC 13G)

Axm Pharma Inc - Statement of Ownership (SC 13G)

Axm Pharma Inc - Current report filing (8-K)

AXM Pharma Receives $2.65 Million Investment From Beida Wei Ming Bioproduct Co., Ltd.

AXM Pharma Hires Leading Chinese Pharmaceutical Sales Executives To Support Growth

AXM Pharma Appoints Steven M. Dinh to Its Board of Directors

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

AXM Pharma Inc (EM) (AXMP)

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

AXM Pharma Inc (EM) (AXMP) Actualités

Current Report Filing (8-k)

Termination of Registration of a Class of Security Under Section 12(b) (15-12b)

- Current report filing (8-K)

Cord Blood America Updates Investors on China and Las Vegas Operations

Cord Blood America's CEO Matthew Schissler, In Analyst Interview, Discusses China Expansion

Cord Blood America Signs License Agreement to Operate Stem Cell Collection Business in China

- Current report filing (8-K)

- Current report filing (8-K)

- Amended Annual Report (10-K/A)

Axm Pharma Inc - Statement of Ownership (SC 13G)

Axm Pharma Inc - Statement of Ownership (SC 13G)

Axm Pharma Inc - Current report filing (8-K)

AXM Pharma Receives $2.65 Million Investment From Beida Wei Ming Bioproduct Co., Ltd.

AXM Pharma Hires Leading Chinese Pharmaceutical Sales Executives To Support Growth

AXM Pharma Appoints Steven M. Dinh to Its Board of Directors

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Pourquoi rejoindre ADVFN?

Tout ce dont les traders professionnels ont besoin.

Supprimer les publicités